+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Biobanking Market by Product (Consumables, Equipment & Instruments, Services), Sample Type (Biological Fluids, Blood Products, Cell Lines), Storage Type, Application, End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 180 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5847154
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Biobanking Market size was estimated at USD 70.33 billion in 2023, USD 78.21 billion in 2024, and is expected to grow at a CAGR of 11.71% to reach USD 152.75 billion by 2030.

It serves various sectors, including pharmaceuticals, biotechnology companies, academic institutions, and healthcare organizations. Applications include drug discovery, diagnostics development, personalized medicine research, and biomarker identification. Rising chronic disease prevalence such as cancer requires early detection and treatment methodologies and necessitates efficient sample storage, increasing deployment of biobanking. Moreover, increasing focus on precision medicine and government investments in national biobank networks are propelling the growth of the market. Furthermore, ensuring sample quality control and maintaining standardized protocols in collecting, processing, and storing samples are major concerns, as inconsistencies can lead to unreliable research outcomes. Data privacy is another pressing issue, with an increasing number of biobanks handling sensitive patient information. Also, leveraging emerging technologies including robotics automation systems for sample handling, enhancing data security through digitalization using blockchain technology, and implementing environmentally sustainable practices including energy-efficient storage units create lucrative opportunities for market growth.

Regional Insights

In the Americas, the US biobanking industry plays a pivotal role in advancing biomedical research through initiatives such as the National Institutes of Health's All of Us Research Program. Furthermore, investments from state governments are driving the establishment of new biobanks. The EU biobanking market is bolstered by collaborations among various countries under initiatives such as Biobanking and BioMolecular resources Research Infrastructure-European Research Infrastructure Consortium (BBMRI-ERIC). Additionally, funding programs, including Horizon 2020, have facilitated advancements in personalized medicine. In Africa, initiatives including H3Africa have promoted the development of biorepositories across the continent to support genomics research on African populations. The APAC region is experiencing rapid growth due to government policies that allocate funds for medical innovation and precision medicine. India hosts several regional biobanks focusing on disease-specific applications such as cancer research.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Biobanking Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Increasing burden of chronic diseases across economies and need for better healthcare infrastructure
  • Growing private and public investments in pharmaceutical research
  • Rising awareness and government initiatives in regenerative medicine

Market Restraints

  • Problems associated with procedure harmonization due to decentralized nature of biobanks

Market Opportunities

  • Ongoing research to improve and ensure standardization of data acquisition and analysis in biobanks
  • Emerging focus on biobank sustainability and development of imaging biobanks

Market Challenges

  • Ethical and legal concerns associated with biobanking

Market Segmentation Analysis

  • Product: Expanding software integration to facilitate the biobanking operations
  • Sample Type: Increasing use of nucleic acid sample for genetic study
  • Storage Type: Rising preference for automated storage systems due to its efficiency and scalability
  • End-User: Expansion of biobanks in pharmaceutical sector for drug development

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Biobanking Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Biobanking Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

New biobanking partnership safeguards the genetic diversity of America's endangered species

Revive & Restore, in collaboration with the U.S. Fish & Wildlife Service, ViaGen Pets & Equine, U.S. Department of Agriculture, and San Diego Zoo Wildlife Alliance, has announced a groundbreaking initiative in biobanking for U.S. endangered species. This multi-institution collaboration establishes the first systematic biobanking pipeline for U.S. threatened and endangered species, safeguarding genetic diversity for present and future recovery efforts. Biobanking entails the intentional and indefinite preservation of living cells, tissues, and gametes.

Crown Bioscience to Acquire Indivumed’s Service Business and Supporting Biobank

Crown Bioscience, a global contract research organization, has signed an agreement to acquire the IndivuServ business unit of Indivumed GmbH. This transaction includes a biobank with nearly one million samples and 60 clinical divisions across the US, Europe, and Asia, providing access to a wide range of biospecimens and blood samples. 'IndivuMed Therapeutics' continues translating high-quality biospecimens into multi-omics data, while Crown Bioscience focuses on offering biomarker development services.

CNIO biobank receives EUR 800,000 from the EU

The REACT Project, led by the National Serum Institute in Denmark (Statens Serum Institute, SSI), has received 7 million euros from the EU to research lower respiratory tract infections in biobanking. In addition to Denmark and Sweden, Spain and South Africa also participate in this initiative. The Spanish National Cancer Center (CNIO) and the Institute of Bioengineering of Catalonia (IBEC) receive almost 25% of the global budget.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Biobanking Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Biobanking Market, highlighting leading vendors and their innovative profiles. These include AMS Biotechnology (Europe) Limited, ASKION GmbH, Avantor, Inc., Azenta Life Sciences, Bay Biosciences LLC, Becton, Dickinson and Company, BioIVT LLC, BioKryo by L’AIR LIQUIDE S.A., BocaBio, Charles River Laboratories International, Inc., Cryoport Systems, LLC, CTIBiotech, Cureline, Inc., Firalis Group, Greiner AG, Hamilton Company, Merck KgaA, Micronic Holding B.V., PHC Holdings Corporation, Promega Corporation, ProteoGenex, QIAGEN N.V., Sopachem NV/SA, SPT Labtech Ltd., STEMCELL Technologies Inc., Taylor-Wharton, Tecan Trading AG, Thermo Fisher Scientific Inc., UK Biobank Limited, and US Biolab Corporation, Inc..

Market Segmentation & Coverage

This research report categorizes the Biobanking Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product

  • Consumables
  • Equipment & Instruments
  • Services
  • Software

Sample Type

  • Biological Fluids
  • Blood Products
  • Cell Lines
  • Human Tissues
  • Nucleic Acids

Storage Type

  • Automated
  • Manual

Application

  • Clinical Research
  • Life Science Research
  • Regenerative Medicine

End-User

  • Academic & Research Institutes
  • Hospitals
  • Pharmaceutical & Biotechnology

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing burden of chronic diseases across economies and need for better healthcare infrastructure
5.1.1.2. Growing private and public investments in pharmaceutical research
5.1.1.3. Rising awareness and government initiatives in regenerative medicine
5.1.2. Restraints
5.1.2.1. Problems associated with procedure harmonization due to decentralized nature of biobanks
5.1.3. Opportunities
5.1.3.1. Ongoing research to improve and ensure standardization of data acquisition and analysis in biobanks
5.1.3.2. Emerging focus on biobank sustainability and development of imaging biobanks
5.1.4. Challenges
5.1.4.1. Ethical and legal concerns associated with biobanking
5.2. Market Segmentation Analysis
5.2.1. Product: Expanding software integration to facilitate the biobanking operations
5.2.2. Sample Type: Increasing use of nucleic acid sample for genetic study
5.2.3. Storage Type: Rising preference for automated storage systems due to its efficiency and scalability
5.2.4. End-User: Expansion of biobanks in pharmaceutical sector for drug development
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Biobanking Market, by Product
6.1. Introduction
6.2. Consumables
6.3. Equipment & Instruments
6.4. Services
6.5. Software
7. Biobanking Market, by Sample Type
7.1. Introduction
7.2. Biological Fluids
7.3. Blood Products
7.4. Cell Lines
7.5. Human Tissues
7.6. Nucleic Acids
8. Biobanking Market, by Storage Type
8.1. Introduction
8.2. Automated
8.3. Manual
9. Biobanking Market, by Application
9.1. Introduction
9.2. Clinical Research
9.3. Life Science Research
9.4. Regenerative Medicine
10. Biobanking Market, by End-User
10.1. Introduction
10.2. Academic & Research Institutes
10.3. Hospitals
10.4. Pharmaceutical & Biotechnology
11. Americas Biobanking Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Biobanking Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Biobanking Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. New biobanking partnership safeguards the genetic diversity of America's endangered species
14.3.2. Crown Bioscience to Acquire Indivumed’s Service Business and Supporting Biobank
14.3.3. CNIO biobank receives EUR 800,000 from the EU
14.4. Strategy Analysis & Recommendation
15. Competitive Portfolio
15.1. Key Company Profiles
15.2. Key Product Portfolio
List of Figures
FIGURE 1. BIOBANKING MARKET RESEARCH PROCESS
FIGURE 2. BIOBANKING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BIOBANKING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BIOBANKING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL BIOBANKING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BIOBANKING MARKET DYNAMICS
FIGURE 7. GLOBAL BIOBANKING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL BIOBANKING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2023 VS 2030 (%)
FIGURE 12. GLOBAL BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOBANKING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 14. GLOBAL BIOBANKING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOBANKING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 16. GLOBAL BIOBANKING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BIOBANKING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS BIOBANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BIOBANKING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES BIOBANKING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. BIOBANKING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 26. BIOBANKING MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. BIOBANKING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BIOBANKING MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL BIOBANKING MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL BIOBANKING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL BIOBANKING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL BIOBANKING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL BIOBANKING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL BIOBANKING MARKET SIZE, BY CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL BIOBANKING MARKET SIZE, BY EQUIPMENT & INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL BIOBANKING MARKET SIZE, BY EQUIPMENT & INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL BIOBANKING MARKET SIZE, BY SERVICES, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL BIOBANKING MARKET SIZE, BY SERVICES, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL BIOBANKING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL BIOBANKING MARKET SIZE, BY SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL BIOBANKING MARKET SIZE, BY BIOLOGICAL FLUIDS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL BIOBANKING MARKET SIZE, BY BIOLOGICAL FLUIDS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL BIOBANKING MARKET SIZE, BY BLOOD PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL BIOBANKING MARKET SIZE, BY BLOOD PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL BIOBANKING MARKET SIZE, BY CELL LINES, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL BIOBANKING MARKET SIZE, BY CELL LINES, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL BIOBANKING MARKET SIZE, BY HUMAN TISSUES, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL BIOBANKING MARKET SIZE, BY HUMAN TISSUES, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL BIOBANKING MARKET SIZE, BY NUCLEIC ACIDS, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL BIOBANKING MARKET SIZE, BY NUCLEIC ACIDS, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL BIOBANKING MARKET SIZE, BY AUTOMATED, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL BIOBANKING MARKET SIZE, BY AUTOMATED, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL BIOBANKING MARKET SIZE, BY MANUAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL BIOBANKING MARKET SIZE, BY MANUAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL BIOBANKING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL BIOBANKING MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL BIOBANKING MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL BIOBANKING MARKET SIZE, BY LIFE SCIENCE RESEARCH, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL BIOBANKING MARKET SIZE, BY LIFE SCIENCE RESEARCH, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL BIOBANKING MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL BIOBANKING MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL BIOBANKING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL BIOBANKING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL BIOBANKING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL BIOBANKING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL BIOBANKING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL BIOBANKING MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL BIOBANKING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL BIOBANKING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. AMERICAS BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 52. AMERICAS BIOBANKING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 53. AMERICAS BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
TABLE 54. AMERICAS BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
TABLE 55. AMERICAS BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2023 (USD MILLION)
TABLE 56. AMERICAS BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2024-2030 (USD MILLION)
TABLE 57. AMERICAS BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 58. AMERICAS BIOBANKING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 59. AMERICAS BIOBANKING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 60. AMERICAS BIOBANKING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 61. AMERICAS BIOBANKING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 62. AMERICAS BIOBANKING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 63. ARGENTINA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 64. ARGENTINA BIOBANKING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 65. ARGENTINA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
TABLE 66. ARGENTINA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
TABLE 67. ARGENTINA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2023 (USD MILLION)
TABLE 68. ARGENTINA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2024-2030 (USD MILLION)
TABLE 69. ARGENTINA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 70. ARGENTINA BIOBANKING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 71. ARGENTINA BIOBANKING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 72. ARGENTINA BIOBANKING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 73. BRAZIL BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 74. BRAZIL BIOBANKING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 75. BRAZIL BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
TABLE 76. BRAZIL BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
TABLE 77. BRAZIL BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2023 (USD MILLION)
TABLE 78. BRAZIL BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2024-2030 (USD MILLION)
TABLE 79. BRAZIL BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 80. BRAZIL BIOBANKING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 81. BRAZIL BIOBANKING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 82. BRAZIL BIOBANKING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 83. CANADA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 84. CANADA BIOBANKING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 85. CANADA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
TABLE 86. CANADA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
TABLE 87. CANADA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2023 (USD MILLION)
TABLE 88. CANADA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2024-2030 (USD MILLION)
TABLE 89. CANADA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 90. CANADA BIOBANKING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 91. CANADA BIOBANKING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 92. CANADA BIOBANKING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 93. MEXICO BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 94. MEXICO BIOBANKING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 95. MEXICO BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
TABLE 96. MEXICO BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
TABLE 97. MEXICO BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2023 (USD MILLION)
TABLE 98. MEXICO BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2024-2030 (USD MILLION)
TABLE 99. MEXICO BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 100. MEXICO BIOBANKING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 101. MEXICO BIOBANKING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 102. MEXICO BIOBANKING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 103. UNITED STATES BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 104. UNITED STATES BIOBANKING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 105. UNITED STATES BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
TABLE 106. UNITED STATES BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
TABLE 107. UNITED STATES BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2023 (USD MILLION)
TABLE 108. UNITED STATES BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2024-2030 (USD MILLION)
TABLE 109. UNITED STATES BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 110. UNITED STATES BIOBANKING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 111. UNITED STATES BIOBANKING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 112. UNITED STATES BIOBANKING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 113. UNITED STATES BIOBANKING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 114. UNITED STATES BIOBANKING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 115. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 116. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 117. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
TABLE 118. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
TABLE 119. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2023 (USD MILLION)
TABLE 120. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2024-2030 (USD MILLION)
TABLE 121. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 122. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 123. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 124. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 125. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 126. ASIA-PACIFIC BIOBANKING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 127. AUSTRALIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 128. AUSTRALIA BIOBANKING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 129. AUSTRALIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
TABLE 130. AUSTRALIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
TABLE 131. AUSTRALIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2023 (USD MILLION)
TABLE 132. AUSTRALIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2024-2030 (USD MILLION)
TABLE 133. AUSTRALIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 134. AUSTRALIA BIOBANKING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 135. AUSTRALIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 136. AUSTRALIA BIOBANKING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 137. CHINA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 138. CHINA BIOBANKING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 139. CHINA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
TABLE 140. CHINA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
TABLE 141. CHINA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2023 (USD MILLION)
TABLE 142. CHINA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2024-2030 (USD MILLION)
TABLE 143. CHINA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 144. CHINA BIOBANKING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 145. CHINA BIOBANKING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 146. CHINA BIOBANKING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 147. INDIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 148. INDIA BIOBANKING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 149. INDIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
TABLE 150. INDIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
TABLE 151. INDIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2023 (USD MILLION)
TABLE 152. INDIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2024-2030 (USD MILLION)
TABLE 153. INDIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 154. INDIA BIOBANKING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 155. INDIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 156. INDIA BIOBANKING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 157. INDONESIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 158. INDONESIA BIOBANKING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 159. INDONESIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
TABLE 160. INDONESIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
TABLE 161. INDONESIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2023 (USD MILLION)
TABLE 162. INDONESIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2024-2030 (USD MILLION)
TABLE 163. INDONESIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 164. INDONESIA BIOBANKING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 165. INDONESIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 166. INDONESIA BIOBANKING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 167. JAPAN BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 168. JAPAN BIOBANKING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 169. JAPAN BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
TABLE 170. JAPAN BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
TABLE 171. JAPAN BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2023 (USD MILLION)
TABLE 172. JAPAN BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2024-2030 (USD MILLION)
TABLE 173. JAPAN BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 174. JAPAN BIOBANKING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 175. JAPAN BIOBANKING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 176. JAPAN BIOBANKING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 177. MALAYSIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 178. MALAYSIA BIOBANKING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 179. MALAYSIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
TABLE 180. MALAYSIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
TABLE 181. MALAYSIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2023 (USD MILLION)
TABLE 182. MALAYSIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2024-2030 (USD MILLION)
TABLE 183. MALAYSIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 184. MALAYSIA BIOBANKING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 185. MALAYSIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 186. MALAYSIA BIOBANKING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 187. PHILIPPINES BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 188. PHILIPPINES BIOBANKING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 189. PHILIPPINES BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
TABLE 190. PHILIPPINES BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
TABLE 191. PHILIPPINES BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2023 (USD MILLION)
TABLE 192. PHILIPPINES BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2024-2030 (USD MILLION)
TABLE 193. PHILIPPINES BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 194. PHILIPPINES BIOBANKING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 195. PHILIPPINES BIOBANKING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 196. PHILIPPINES BIOBANKING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 197. SINGAPORE BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 198. SINGAPORE BIOBANKING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 199. SINGAPORE BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
TABLE 200. SINGAPORE BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
TABLE 201. SINGAPORE BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2023 (USD MILLION)
TABLE 202. SINGAPORE BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2024-2030 (USD MILLION)
TABLE 203. SINGAPORE BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 204. SINGAPORE BIOBANKING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 205. SINGAPORE BIOBANKING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 206. SINGAPORE BIOBANKING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 207. SOUTH KOREA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 208. SOUTH KOREA BIOBANKING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 209. SOUTH KOREA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
TABLE 210. SOUTH KOREA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
TABLE 211. SOUTH KOREA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2023 (USD MILLION)
TABLE 212. SOUTH KOREA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2024-2030 (USD MILLION)
TABLE 213. SOUTH KOREA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 214. SOUTH KOREA BIOBANKING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 215. SOUTH KOREA BIOBANKING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 216. SOUTH KOREA BIOBANKING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 217. TAIWAN BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 218. TAIWAN BIOBANKING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 219. TAIWAN BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
TABLE 220. TAIWAN BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
TABLE 221. TAIWAN BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2023 (USD MILLION)
TABLE 222. TAIWAN BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2024-2030 (USD MILLION)
TABLE 223. TAIWAN BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 224. TAIWAN BIOBANKING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 225. TAIWAN BIOBANKING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 226. TAIWAN BIOBANKING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 227. THAILAND BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 228. THAILAND BIOBANKING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 229. THAILAND BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
TABLE 230. THAILAND BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
TABLE 231. THAILAND BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2023 (USD MILLION)
TABLE 232. THAILAND BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2024-2030 (USD MILLION)
TABLE 233. THAILAND BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 234. THAILAND BIOBANKING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 235. THAILAND BIOBANKING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 236. THAILAND BIOBANKING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 237. VIETNAM BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 238. VIETNAM BIOBANKING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 239. VIETNAM BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
TABLE 240. VIETNAM BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
TABLE 241. VIETNAM BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2023 (USD MILLION)
TABLE 242. VIETNAM BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2024-2030 (USD MILLION)
TABLE 243. VIETNAM BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 244. VIETNAM BIOBANKING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 245. VIETNAM BIOBANKING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 246. VIETNAM BIOBANKING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2023 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2024-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA BIOBANKING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 259. DENMARK BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 260. DENMARK BIOBANKING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 261. DENMARK BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
TABLE 262. DENMARK BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
TABLE 263. DENMARK BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2023 (USD MILLION)
TABLE 264. DENMARK BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2024-2030 (USD MILLION)
TABLE 265. DENMARK BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 266. DENMARK BIOBANKING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 267. DENMARK BIOBANKING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 268. DENMARK BIOBANKING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 269. EGYPT BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 270. EGYPT BIOBANKING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 271. EGYPT BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
TABLE 272. EGYPT BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
TABLE 273. EGYPT BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2023 (USD MILLION)
TABLE 274. EGYPT BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2024-2030 (USD MILLION)
TABLE 275. EGYPT BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 276. EGYPT BIOBANKING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 277. EGYPT BIOBANKING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 278. EGYPT BIOBANKING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 279. FINLAND BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 280. FINLAND BIOBANKING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 281. FINLAND BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
TABLE 282. FINLAND BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
TABLE 283. FINLAND BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2023 (USD MILLION)
TABLE 284. FINLAND BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2024-2030 (USD MILLION)
TABLE 285. FINLAND BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 286. FINLAND BIOBANKING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 287. FINLAND BIOBANKING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 288. FINLAND BIOBANKING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 289. FRANCE BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 290. FRANCE BIOBANKING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 291. FRANCE BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
TABLE 292. FRANCE BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
TABLE 293. FRANCE BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2023 (USD MILLION)
TABLE 294. FRANCE BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2024-2030 (USD MILLION)
TABLE 295. FRANCE BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 296. FRANCE BIOBANKING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 297. FRANCE BIOBANKING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 298. FRANCE BIOBANKING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 299. GERMANY BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 300. GERMANY BIOBANKING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 301. GERMANY BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
TABLE 302. GERMANY BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
TABLE 303. GERMANY BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2023 (USD MILLION)
TABLE 304. GERMANY BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2024-2030 (USD MILLION)
TABLE 305. GERMANY BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 306. GERMANY BIOBANKING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 307. GERMANY BIOBANKING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 308. GERMANY BIOBANKING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 309. ISRAEL BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 310. ISRAEL BIOBANKING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 311. ISRAEL BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
TABLE 312. ISRAEL BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
TABLE 313. ISRAEL BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2023 (USD MILLION)
TABLE 314. ISRAEL BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2024-2030 (USD MILLION)
TABLE 315. ISRAEL BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 316. ISRAEL BIOBANKING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 317. ISRAEL BIOBANKING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 318. ISRAEL BIOBANKING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 319. ITALY BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 320. ITALY BIOBANKING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 321. ITALY BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
TABLE 322. ITALY BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
TABLE 323. ITALY BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2023 (USD MILLION)
TABLE 324. ITALY BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2024-2030 (USD MILLION)
TABLE 325. ITALY BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 326. ITALY BIOBANKING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 327. ITALY BIOBANKING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 328. ITALY BIOBANKING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 329. NETHERLANDS BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 330. NETHERLANDS BIOBANKING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 331. NETHERLANDS BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
TABLE 332. NETHERLANDS BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
TABLE 333. NETHERLANDS BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2023 (USD MILLION)
TABLE 334. NETHERLANDS BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2024-2030 (USD MILLION)
TABLE 335. NETHERLANDS BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 336. NETHERLANDS BIOBANKING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 337. NETHERLANDS BIOBANKING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 338. NETHERLANDS BIOBANKING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 339. NIGERIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 340. NIGERIA BIOBANKING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 341. NIGERIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
TABLE 342. NIGERIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
TABLE 343. NIGERIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2023 (USD MILLION)
TABLE 344. NIGERIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2024-2030 (USD MILLION)
TABLE 345. NIGERIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 346. NIGERIA BIOBANKING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 347. NIGERIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 348. NIGERIA BIOBANKING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 349. NORWAY BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 350. NORWAY BIOBANKING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 351. NORWAY BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
TABLE 352. NORWAY BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
TABLE 353. NORWAY BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2023 (USD MILLION)
TABLE 354. NORWAY BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2024-2030 (USD MILLION)
TABLE 355. NORWAY BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 356. NORWAY BIOBANKING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 357. NORWAY BIOBANKING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 358. NORWAY BIOBANKING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 359. POLAND BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 360. POLAND BIOBANKING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 361. POLAND BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
TABLE 362. POLAND BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
TABLE 363. POLAND BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2023 (USD MILLION)
TABLE 364. POLAND BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2024-2030 (USD MILLION)
TABLE 365. POLAND BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 366. POLAND BIOBANKING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 367. POLAND BIOBANKING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 368. POLAND BIOBANKING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 369. QATAR BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 370. QATAR BIOBANKING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 371. QATAR BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
TABLE 372. QATAR BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
TABLE 373. QATAR BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2023 (USD MILLION)
TABLE 374. QATAR BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2024-2030 (USD MILLION)
TABLE 375. QATAR BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 376. QATAR BIOBANKING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 377. QATAR BIOBANKING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 378. QATAR BIOBANKING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 379. RUSSIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 380. RUSSIA BIOBANKING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 381. RUSSIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
TABLE 382. RUSSIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (USD MILLION)
TABLE 383. RUSSIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2018-2023 (USD MILLION)
TABLE 384. RUSSIA BIOBANKING MARKET SIZE, BY STORAGE TYPE, 2024-2030 (USD MILLION)
TABLE 385. RUSSIA BIOBANKING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 386. RUSSIA BIOBANKING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 387. RUSSIA BIOBANKING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 388. RUSSIA BIOBANKING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 389. SAUDI ARABIA BIOBANKING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 390. SAUDI ARABIA BIOBANKING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 391. SAUDI ARABIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2018-2023 (USD MILLION)
TABLE 392. SAUDI ARABIA BIOBANKING MARKET SIZE, BY SAMPLE TYPE, 2024-2030 (US

Companies Mentioned

  • AMS Biotechnology (Europe) Limited
  • ASKION GmbH
  • Avantor, Inc.
  • Azenta Life Sciences
  • Bay Biosciences LLC
  • Becton, Dickinson and Company
  • BioIVT LLC
  • BioKryo by L’AIR LIQUIDE S.A.
  • BocaBio
  • Charles River Laboratories International, Inc.
  • Cryoport Systems, LLC
  • CTIBiotech
  • Cureline, Inc.
  • Firalis Group
  • Greiner AG
  • Hamilton Company
  • Merck KgaA
  • Micronic Holding B.V.
  • PHC Holdings Corporation
  • Promega Corporation
  • ProteoGenex
  • QIAGEN N.V.
  • Sopachem NV/SA
  • SPT Labtech Ltd.
  • STEMCELL Technologies Inc.
  • Taylor-Wharton
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • UK Biobank Limited
  • US Biolab Corporation, Inc.

Methodology

Loading
LOADING...

Table Information